Prognostic significance of lymph node metastasis found during pulmonary metastasectomy for extrapulmonary carcinoma Sina Ercan, MD, Francis C Nichols,

Slides:

Advertisements

Similar presentations

Surgical treatment of hepatic and pulmonary metastases from colon cancer James R Headrick, MD, Daniel L Miller, MD, David M Nagorney, MD, Mark S Allen,

Advertisements

The STS National Database

Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.

Leena Khaitan, MD, Francis P Sutter, Scott M Goldman, MD

Primary non-Hodgkin’s lymphoma of the lung

Masatsugu Hamaji, MD, Stephen D. Cassivi, MD, K

Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients Ze Fen Xiao, MD, Zong Yi Yang, MD, Jun Liang, MD, Yan.

Closed drainage using Redon catheters for poststernotomy mediastinitis: results and risk factors for adverse outcome Matthias Kirsch, MD, Armand Mekontso-Dessap,

Collision Tumor of Esophagus: Report of Three Cases

Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than.

Tetralogy of Fallot: surgical management individualized to the patient

Surgical Results and Prognostic Factors in Early Non–Small Cell Lung Cancer José Padilla, MD, Vı́ctor Calvo, MD, Juan C Peñalver, MD, Gabriel Sales, MD,

High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy James R Headrick, MD, Francis C Nichols, MD, Daniel L Miller,

Prognostic factors and survival after complete resection of pulmonary metastases from colorectal carcinoma: Experiences in 167 patients Joachim Pfannschmidt,

Salvage Resections for Recurrent or Persistent Cancer of the Proximal Esophagus After Chemoradiotherapy Colin Schieman, MD, Dennis A. Wigle, MD, PhD,

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Surgery for acute type A aortic dissection: the Hopital Foch experience (1977–1998) Jean Bachet, MD, Bertrand Goudot, MD, Gilles D Dreyfus, MD, Denis.

Prognostic Value of Different Lymph Node Staging Methods in Esophageal Squamous Cell Carcinoma After Esophagectomy San-Gang Wu, MD, Feng-Yan Li, MD,

Esophageal Resection for Cancer of the Esophagus: Long-Term Function and Quality of Life Allison J McLarty, MD, Claude Deschamps, MD, Victor F Trastek,

Surgical treatment of hepatic and pulmonary metastases from colon cancer James R Headrick, MD, Daniel L Miller, MD, David M Nagorney, MD, Mark S Allen,

Esophagectomy Outcomes in the Endoscopic Mucosal Resection Era

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Jong Ho Cho, MD, Masatsugu Hamaji, MD, Mark S. Allen, MD, Stephen D

Risk Factors for Lymph Node Metastases and Prognosticators of Survival in Patients Undergoing Pulmonary Metastasectomy for Colorectal Cancer Servet Bölükbas,

K. Robert Shen, MD, Mark S. Allen, MD, Stephen D

A Randomized Controlled Trial of Bupivacaine Through Intracostal Catheters for Pain Management After Thoracotomy Mark S. Allen, MD, Lisa Halgren, RN,

Brendon M. Stiles, MD, Farooq Mirza, MD, Jeffrey L. Port, MD, Paul C

Factors predicting patterns of recurrence after resection of N1 non-small cell lung carcinoma Timothy E Sawyer, MD, James A Bonner, MD, Perry M Gould,

Lobe-specific extent of systematic lymph node dissection for non–small cell lung carcinomas according to a retrospective study of metastasis and prognosis

Combined Resection of Superior Vena Cava for Lung Carcinoma: Prognostic Significance of Patterns of Superior Vena Cava Invasion Kenji Suzuki, MD, Hisao.

Theolyn N. Price, MD, Mark S. Allen, MD, Francis C

Surgical treatment of non-small cell lung cancer 1 cm or less in diameter Daniel L Miller, MD, Charles M Rowland, MS, Claude Deschamps, MD, Mark S Allen,

Surgical Resection of Rare Esophageal Cancers

Large cell neuroendocrine carcinoma and large cell carcinomas with neuroendocrine morphology of the lung: prognosis after complete resection and systematic.

Karen M. Harrison–Phipps, MD, Francis C. Nichols, MD, Cathy D

Long-term results after pulmonary resection of renal cell carcinoma metastases Stefan Piltz, MD, Georgios Meimarakis, MD, Matthias W Wichmann, MD, Rudolf.

Clinical outcomes and changes in lung function after segmentectomy versus lobectomy for lung cancer cases Bo Deng, MD, PhD, Stephen D. Cassivi, MD, Mariza.

Lobar torsion after pulmonary resection: Presentation and outcome

Bronchobiliary fistula: principles of management

Leiomyosarcoma of the esophagus: results of surgical treatment

Better pulmonary function and prognosis with video-assisted thoracic surgery than with thoracotomy Shizuka Kaseda, MD, Teruhiro Aoki, MD, Nanae Hangai,

Postpneumonectomy Empyema: Results After the Clagett Procedure

The Prognostic Value of the Number of Negative Lymph Nodes in Esophageal Cancer Patients After Transthoracic Resection Po-Kuei Hsu, MD, Chien-Sheng Huang,

Nodal Skip Metastasis in Esophageal Squamous Cell Carcinoma Patients Undergoing Three-Field Lymphadenectomy Feng Wang, MD, Yuzhen Zheng, MD, Zhen Wang,

Valerie W Rusch, MD, Ennapadam S Venkatraman, PhD

Importance of Lymph Node Dissection in Thymic Carcinoma

Extent of Lymphadenectomy Is Associated With Improved Overall Survival After Esophagectomy With or Without Induction Therapy Pamela Samson, MD, MPHS,

Selective Mediastinal Lymphadenectomy for Clinico-Surgical Stage I Non–Small Cell Lung Cancer Morihito Okada, MD, PhD, Toshihiko Sakamoto, MD, PhD, Tsuyoshi.

Superior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis Shun-ichi Watanabe, MD, Kenji Suzuki,

Refining the Nodal Staging for Esophageal Squamous Cell Carcinoma Based on Lymph Node Stations Jun Peng, MD, Wen-Ping Wang, MD, Ting Dong, MD, Jie Cai,

Value of systematic mediastinal lymph node dissection during pulmonary metastasectomy Florian Loehe, MD, Sonja Kobinger, MD, Rudolf A Hatz, MD, Thomas.

A Strategy for Determining Which Thoracic Esophageal Cancer Patients Should Undergo Cervical Lymph Node Dissection Shiro Nagatani, MD, Yutaka Shimada,

Carcinoma of the esophagus: Prognostic significance of histologic type

Attila Dubecz, MD, Thomas J. Watson, MD, Daniel P

Surgical management of sternoclavicular joint infections

Role of surgical resection in broncholithiasis

Is there a role for pneumonectomy in pulmonary metastases?1

Bullectomy for Symptomatic or Complicated Giant Lung Bullae

Qing-yu Wu, MD The Annals of Thoracic Surgery

The American Board of Thoracic Surgery: Update

Neal S Goldstein, MD The Annals of Thoracic Surgery

Effectiveness of Postoperative Irradiation in Stage IIIA Non–Small Cell Lung Cancer According to Regression Tree Analyses of Recurrence Risks Timothy.

Experience With Bovine Pericardium for the Reconstruction of the Aortic Arch in Patients Undergoing a Norwood Procedure Victor O. Morell, MD, Peter A.

Mark I. Block, MD The Annals of Thoracic Surgery

The Annals of Thoracic Surgery

Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma Joachim Pfannschmidt, MD, Hans Hoffmann, MD, PhD, Thomas.

Outcome after Pulmonary Metastasectomy: Analysis of 5 Years Consecutive Surgical Resections 2002–2006 Kåre Hornbech, MD, Jesper Ravn, MD, Daniel Andreas.

Zenker’s diverticulum in the elderly: is operation justified?

Surgery for pulmonary metastases from colorectal carcinoma

Presentation transcript:

Prognostic significance of lymph node metastasis found during pulmonary metastasectomy for extrapulmonary carcinoma Sina Ercan, MD, Francis C Nichols, MD, Victor F Trastek, MD, Claude Deschamps, MD, Mark S Allen, MD, Daniel L Miller, MD, Cathy D Schleck, BS, Peter C Pairolero, MD The Annals of Thoracic Surgery Volume 77, Issue 5, Pages 1786-1791 (May 2004) DOI: 10.1016/S0003-4975(03)01200-1

Fig 1 Estimated survival (death due to any cause) of 70 patients undergoing pulmonary metastasectomy and complete mediastinal lymph node dissection. Zero time on the abscissa is date of first pulmonary metastasectomy and lymph node dissection. The Annals of Thoracic Surgery 2004 77, 1786-1791DOI: (10.1016/S0003-4975(03)01200-1)

Fig 2 Estimated survival of 70 patients undergoing pulmonary metastasectomy and complete mediastinal lymphadenectomy without metastatic nodal involvement (negative) and with nodal involvement (positive). Zero time on the abscissa is date of first pulmonary metastasectomy and lymph node dissection. (p < 0.001). The Annals of Thoracic Surgery 2004 77, 1786-1791DOI: (10.1016/S0003-4975(03)01200-1)